Evening star., 1953-05-10
Controversy Rages
On Krebiozen's Role
As Cancer Drug
Nv the Assoeiniad Prasa

CHICAGO, May "a letter
to DR.. Andrew C. Ivy declaring
he would be sunk and you and
your family will suffer" unless
DR.. Ivy publicly denounced
krebiozen as a worthless cancer
drug came to light today in a
battle" Of statements.
A special committee of the
Illinois legislature investigating
the krebiozen controversy re-
fused to accept an unsigned copy
of the letter in evidence.
But it was made public in
somewhat different texts by the
opposing sides. A. L. Hodson, an
attorney for the American Medi-
cal Association, charged that the
letter had been "slanted" and
its meaning changed" by dele
ton Of several paragraphs in the
copy offered for evidence.
Portions Are Deleted.
DR.. Ivy said portions of the let
ter were deleted because they
were not pertinent to the investi-
cation which is designed to de-
termine whether the University
of Illinois was justified in drop
ping research on KrebioZen.
Supporters of Krebfozen had
offered a copy of the letter in
an effort to support charges that
a commercial conspiracy had
been waged to smear" DR.. Ivy,
internationally known phySiolo-
giSt and vice president of the
University of Illinois.
Meanwhile, the ANA, which
has published the results of
studies stating that krebiozen
was without beneficial effect on
cancer. reiterated it's position in
. statement. and added:
1T should be made clear to
the committee and to the public
that the ANA has promoted the
production and distribution of
innumerable wonder drugs" like
aureomycin, penicillin and many
others, and that under no cir
cumstances would it prevent the
development of any drug which
would benefit humanity"
Writer'S Name Withheld.
The statement was issued by
DR.. Ernest B. Howard, assistant
general manager of the ANA.
The letter, written in August,
1851, forecast that DR.. Ivy would
lose his good standing in the
Chicago medical society and his
post at the University of Illinois
would be taken away from him
unless he denounced krebiozen
in the ANA journal.
DR.. Ivy, a pioneer and key
figure in krebiozen research, sub
sequently was suspended for
three months by the Chicago
Medical Society. President t
George D. Stoddard of the Uni
versity of Illinois has recon-
mended that DR.. Ivy's post as
vice president of the university
be abolished with DR.. Ivy re-
manning on as head of the de-
partment of clinical studies, but
the universit trustees have taken
no action on this.
DR.. Ivy submitted the letter as
an exhibit. He did not disclose
the name of the writer but Of
fered to supply it to the COM
mittee in confidence.
ANA Preparing Report.
Krebiozen supporters, mean
while. furnished copies to news
men.
Then Mr.. HodSon held an i'm
prOmptu press conference in a
corridor outside the hearing
room and introduced Franklin
c. Bing, a Chicago consulting
chemist who said he sent the let
ter to DR.. Ivy. Mr.. Bing, former
SCCIC y W Vic H4N4A SOOAAN11 OAA
foods and nutrition, termed the
copy a "mutilated version"
Both versions of the letter
stated that DR.. Ivy was in a
critical situation" They said
the ANA was preparing a de
vastating" report against Krebi-
oten that would cost DR.. Ivy his
standing as a doctor, his post at
the university, his connection
with national medical commit
tees and his chance to conduct
research in any reputable insti-
tuition.
The letter urged DR.. Ivy to do
"the one constructive thing that
you can do"-write a letter to
the ANA saying that. "Krekiozen
has no value in the treatment of
cancer"